Literature DB >> 24813895

Regulation of FAS exon definition and apoptosis by the Ewing sarcoma protein.

Maria Paola Paronetto1, Isabella Bernardis2, Elisabetta Volpe3, Elias Bechara4, Endre Sebestyén2, Eduardo Eyras5, Juan Valcárcel6.   

Abstract

The Ewing sarcoma protein EWS is an RNA and DNA binding protein implicated in transcription, pre-mRNA splicing, and DNA damage response. Using CLIP-seq, we identified EWS RNA binding sites in exonic regions near 5' splice sites. A prominent target was exon 6 of the FAS/CD95 receptor, which is alternatively spliced to generate isoforms with opposing activities in programmed cell death. Depletion and overexpression experiments showed that EWS promotes exon 6 inclusion and consequently the synthesis of the proapoptotic FAS/CD95 isoform, whereas an EWS-FLI1 fusion protein characteristic of Ewing sarcomas shows decreased activity. Biochemical analyses revealed that EWS binding promotes the recruitment of U1snRNP and U2AF65 to the splice sites flanking exon 6 and therefore exon definition. Consistent with a role for EWS in the regulation of programmed cell death, cells depleted of EWS show decreased sensitivity to FAS-induced apoptosis, and elevated EWS expression enhances apoptosis in EWS-haploinsufficient Ewing sarcoma cells.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24813895     DOI: 10.1016/j.celrep.2014.03.077

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  31 in total

1.  Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.

Authors:  Saravana P Selvanathan; Garrett T Graham; Hayriye V Erkizan; Uta Dirksen; Thanemozhi G Natarajan; Aleksandra Dakic; Songtao Yu; Xuefeng Liu; Michelle T Paulsen; Mats E Ljungman; Cathy H Wu; Elizabeth R Lawlor; Aykut Üren; Jeffrey A Toretsky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

2.  An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.

Authors:  Vivekananda Kedage; Nagarathinam Selvaraj; Taylor R Nicholas; Justin A Budka; Joshua P Plotnik; Travis J Jerde; Peter C Hollenhorst
Journal:  Cell Rep       Date:  2016-10-25       Impact factor: 9.423

Review 3.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

Review 4.  Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?

Authors:  Elizabeth R Lawlor; Poul H Sorensen
Journal:  Crit Rev Oncog       Date:  2015

Review 5.  Alternative splicing and cell survival: from tissue homeostasis to disease.

Authors:  Maria Paola Paronetto; Ilaria Passacantilli; Claudio Sette
Journal:  Cell Death Differ       Date:  2016-09-30       Impact factor: 15.828

6.  The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS.

Authors:  Sujitha Duggimpudi; Erik Larsson; Schafiq Nabhani; Arndt Borkhardt; Jessica I Hoell
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

Review 7.  Splicing Regulation: A Molecular Device to Enhance Cancer Cell Adaptation.

Authors:  Vittoria Pagliarini; Chiara Naro; Claudio Sette
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

8.  The interplay between DNA damage response and RNA processing: the unexpected role of splicing factors as gatekeepers of genome stability.

Authors:  Chiara Naro; Pamela Bielli; Vittoria Pagliarini; Claudio Sette
Journal:  Front Genet       Date:  2015-04-15       Impact factor: 4.599

9.  The RNA binding protein Sam68 controls T helper 1 differentiation and anti-mycobacterial response through modulation of miR-29.

Authors:  Elisabetta Volpe; Eleonora Cesari; Neri Mercatelli; Rosella Cicconi; Marco De Bardi; Alessia Capone; Davide Bonvissuto; Maurizio Fraziano; Maurizio Mattei; Luca Battistini; Maria Paola Paronetto; Claudio Sette
Journal:  Cell Death Differ       Date:  2018-09-26       Impact factor: 15.828

Review 10.  Splicing alterations in healthy aging and disease.

Authors:  Brittany Lynn Angarola; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-09       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.